Psylocibin Suicide

Groundbreaking study that included a vulnerable population previously excluded from studies. Dr. Scott Aaronson and Dr. Andrew van der Vaart discuss their Journal of Clinical Psychiatry open-label, single-arm 12-week trial testing a single 25 mg dose of COMP360 psilocybin with psychological...